tiprankstipranks
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
Holding AUTL?
Track your performance easily

Autolus Therapeutics (AUTL) Financial Statements

611 Followers

Autolus Therapeutics Financial Overview

Autolus Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.208; its P/E ratio is -1.90; Autolus Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 22Sep 22
Income Statement-
Total Revenue$ 63.00K$ 61.00K$ 10.09M-$ 2.37M
Gross Profit$ 63.00K$ 61.00K$ 10.09M--
EBIT$ -71.39M$ -48.05M$ -33.43M-$ -47.07M
EBITDA$ -69.45M$ -46.15M$ -31.62M-$ -45.28M
Net Income Common Stockholders$ -82.09M$ -48.10M$ -52.69M-$ -42.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 657.07M$ 705.94M$ 758.53M$ 382.76M$ 163.05M
Total Assets$ 827.49M$ 853.62M$ 901.44M$ 490.27M$ 263.83M
Total Debt$ 52.23M$ 50.02M$ 51.34M$ 24.26M$ 15.13M
Net Debt$ -604.84M$ -655.92M$ -707.19M$ -358.50M$ -147.93M
Total Liabilities$ 350.52M$ 325.78M$ 319.41M$ 191.60M$ 102.68M
Stockholders Equity$ 476.96M$ 527.73M$ 582.03M$ 298.67M$ 161.15M
Cash Flow-
Free Cash Flow$ -86.33M$ -51.92M$ -41.05M-$ -38.70M
Operating Cash Flow$ -76.74M$ -51.08M$ -40.51M-$ -31.90M
Investing Cash Flow$ -9.59M$ -841.00K$ -533.00K-$ -6.80M
Financing Cash Flow$ 185.00K$ -2.08M$ 561.44M-$ 102.00K
Currency in USD

Autolus Therapeutics Earnings and Revenue History

Autolus Therapeutics Debt to Assets

Autolus Therapeutics Cash Flow

Autolus Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis